Literature DB >> 3475897

The TSH receptor: structure and interaction with autoantibodies in thyroid disease.

J Furmaniak, Y Nakajima, F A Hashim, F M Creagh, E Davies Jones, R D Howells, S M McLachlan, B Rees Smith.   

Abstract

Studies of the TSH receptor using affinity labelling with photoactive derivatives of TSH and analysis by SDS-PAGE have shown that the receptor contains 2 subunits (A and B), linked by a disulphide bridge. Similar results are obtained with TSH receptors from human, porcine and guinea pig thyroid tissue and from guinea pig fat. Analysis of affinity labelled receptors under non-denaturing conditions suggest that subunits additional to the A and B subunits are not present. Hydrodynamic measurements indicate that the receptor A subunit has an approximately spherical structure (Stokes' radius 70 A) and when this interacts with TSH (an elongated structure with Stokes' radius 56A) a very elongated complex (Stokes' radius 104A) is formed. Isoelectric focusing studies of the TSH receptor A subunit, TSH and TSH receptor antibodies indicate that charge-charge interactions are of considerable importance in the binding of hormone and antibody to the receptor.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3475897     DOI: 10.1530/acta.0.114s157

Source DB:  PubMed          Journal:  Acta Endocrinol Suppl (Copenh)        ISSN: 0300-9750


  3 in total

Review 1.  Autoantigens in thyroid diseases.

Authors:  K Dawe; P Hutchings; B Champion; A Cooke; I Roitt
Journal:  Springer Semin Immunopathol       Date:  1993

2.  Pathogenetic role of thyrotropin receptor antibody in the development of hyperthyroidism following primary hypothyroidism.

Authors:  Y K Shong; B Y Cho; S K Hong; H K Lee; C S Koh; H K Min
Journal:  Korean J Intern Med       Date:  1989-07       Impact factor: 2.884

3.  Changes in the properties of the thyrotropin receptor antibody in patients with Graves' disease after radioiodine treatment.

Authors:  B Y Cho; Y K Shong; J K Chung; M C Lee; H K Lee; C S Koh; H K Min
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.